Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
57.29
-0.82 (-1.41%)
Mar 20, 2026, 2:13 PM EDT - Market open
BMY Employees
Bristol-Myers Squibb Company had 32,500 employees as of December 31, 2025. The number of employees decreased by 1,600 or -4.69% compared to the previous year.
Employees
32,500
Change (1Y)
-1,600
Growth (1Y)
-4.69%
Revenue / Employee
$1,482,892
Profits / Employee
$217,046
Market Cap
116.67B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32,500 | -1,600 | -4.69% |
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | 30,000 | 6,700 | 28.76% |
| Dec 31, 2018 | 23,300 | -400 | -1.69% |
| Dec 31, 2017 | 23,700 | -1,300 | -5.20% |
| Dec 31, 2016 | 25,000 | 0 | - |
| Dec 31, 2015 | 25,000 | 0 | - |
| Dec 31, 2014 | 25,000 | -3,000 | -10.71% |
| Dec 31, 2013 | 28,000 | 0 | - |
| Dec 31, 2012 | 28,000 | 1,000 | 3.70% |
| Dec 31, 2011 | 27,000 | 0 | - |
| Dec 31, 2010 | 27,000 | -1,000 | -3.57% |
| Dec 31, 2009 | 28,000 | -7,000 | -20.00% |
| Dec 31, 2008 | 35,000 | -7,000 | -16.67% |
| Dec 31, 2007 | 42,000 | -1,000 | -2.33% |
| Dec 31, 2006 | 43,000 | 0 | - |
| Dec 31, 2005 | 43,000 | 0 | - |
| Dec 31, 2004 | 43,000 | -1,000 | -2.27% |
| Dec 31, 2003 | 44,000 | 0 | - |
| Dec 31, 2002 | 44,000 | -2,000 | -4.35% |
| Dec 31, 2001 | 46,000 | 2,000 | 4.55% |
| Dec 31, 2000 | 44,000 | -10,500 | -19.27% |
| Dec 31, 1999 | 54,500 | -200 | -0.37% |
| Dec 31, 1998 | 54,700 | 1,100 | 2.05% |
| Dec 31, 1997 | 53,600 | 2,400 | 4.69% |
| Dec 31, 1996 | 51,200 | 2,060 | 4.19% |
| Dec 31, 1995 | 49,140 | 1,440 | 3.02% |
| Dec 31, 1994 | 47,700 | -1,800 | -3.64% |
| Dec 31, 1993 | 49,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
BMY News
- 19 minutes ago - Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma - Benzinga
- 1 hour ago - US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma - Reuters
- 1 day ago - Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 - Business Wire
- 1 day ago - TrumpRx lists many medicines at prices higher than paid in UK - Reuters
- 2 days ago - Don't Miss This 14% Yield And This Pharma Value Stock - Seeking Alpha
- 10 days ago - Virtus Large Cap Growth SMA Q4 2025 Portfolio Review - Seeking Alpha
- 11 days ago - Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma - Business Wire
- 13 days ago - U.S. FDA Approves Bristol Myers Squibb's Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis - Business Wire